Latest Breaking News On - Raffaele baffa - Page 1 : comparemela.com

CARsgen's Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

CARsgen's CT011 receives IND clearance from China's NMPA

CARsgen announced that its autologous CAR T-cell product candidate, CT011, received Investigational New Drug (IND) clearance from the NMPA in China.

CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection

SHANGHAI, Jan. 15, 2024 /PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for

CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage ?a hepatocellular carcinoma at high risk of recurrence after surgical resection

Carsgen's CT011 Achieves IND Clearance From The NMPA For The GPC3-Positive Stage Iiia Hepatocellular Carcinoma At High Risk Of Recurrence After Surgic...